Novel compound heterozygous mutations in the OTOF Gene identified by whole-exome sequencing in auditory neuropathy spectrum disorder by Fengzhu Tang et al.
RESEARCH ARTICLE Open Access
Novel compound heterozygous mutations
in the OTOF Gene identified by whole-
exome sequencing in auditory neuropathy
spectrum disorder
Fengzhu Tang1†, Dengke Ma2†, Yulan Wang2†, Yuecai Qiu2, Fei Liu3, Qingqing Wang2, Qiutian Lu1, Min Shi1,
Liang Xu1, Min Liu1 and Jianping Liang1*
Abstract
Background: Many hearing-loss diseases are demonstrated to have Mendelian inheritance caused by mutations
in single gene. However, many deaf individuals have diseases that remain genetically unexplained. Auditory
neuropathy is a sensorineural deafness in which sounds are able to be transferred into the inner ear normally
but the transmission of the signals from inner ear to auditory nerve and brain is injured, also known as auditory
neuropathy spectrum disorder (ANSD). The pathogenic mutations of the genes responsible for the Chinese ANSD
population remain poorly understood.
Methods: A total of 127 patients with non-syndromic hearing loss (NSHL) were enrolled in Guangxi Zhuang
Autonomous Region. A hereditary deafness gene mutation screening was performed to identify the mutation
sites in four deafness-related genes (GJB2, GJB3, 12S rRNA, and SLC26A4). In addition, whole-exome sequencing
(WES) was applied to explore unappreciated mutation sites in the cases with the singularity of its phenotype.
Results: Well-characterized mutations were found in only 8.7% (11/127) of the patients. Interestingly, two
mutations in the OTOF gene were identified in two affected siblings with ANSD from a Chinese family,
including one nonsense mutation c.1273C > T (p.R425X) and one missense mutation c.4994 T > C (p.L1665P).
Furthermore, we employed Sanger sequencing to confirm the mutations in each subject. Two compound
heterozygous mutations in the OTOF gene were observed in the two affected siblings, whereas the two
parents and unaffected sister were heterozygous carriers of c.1273C > T (father and sister) and c.4994 T > C
(mother). The nonsense mutation p.R425X, contributes to a premature stop codon, may result in a truncated
polypeptide, which strongly suggests its pathogenicity for ANSD. The missense mutation p.L1665P results in
a single amino acid substitution in a highly conserved region.
Conclusions: Two mutations in the OTOF gene in the Chinese deaf population were recognized for the
first time. These findings not only extend the OTOF gene mutation spectrum for ANSD but also indicate
that whole-exome sequencing is an effective approach to clarify the genetic characteristics in non-syndromic
ANSD patients.
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Background
Deafness is one of the most common clinical oto-
logical diseases, and most cases are caused by genetic
factors [1, 2]. Hereditary hearing loss has high
genetic heterogeneity, non-syndromic hearing loss
(NSHL) has only the symptom of deafness and ac-
counts for 70% of all hereditary deafness, while syn-
dromic deafness accounts for 30% of all cases [1, 2].
The majority of NSHL has been confirmed to have
Mendelian inheritance from single gene mutations,
and these cases mainly include autosomal recessive
or autosomal dominant transmission and X-linked or
mitochondrial inheritance [3]. More than 90 genes
related to NSHL have been identified. Earlier studies
have shown mutations in several genes that are
closely related to NSHL in China, such as mtDNA
12S-rRNA, SLC26A4, GJB2, GJB3, and GJB6 [4],
while the causes of disease in other deaf individuals
remain unknown.
Whole-exome sequencing (WES) is a novel tech-
nique that has offered a breakthrough for studying
rare Mendelian diseases that allows for sequencing of
all expressed genes in the genome, which is substan-
tial considering the protein-coding regions covers ap-
proximately 85% of human disease-causing mutations
[5]. WES is a novel technique of genome analysis
that has the advantages of being simple, economical
and accurate, and it has become the most efficient
way to identify genetic variants in all genes for an
individual [6].
Auditory neuropathy spectrum disorder (ANSD) is
considered as a type of autosomal recessive non-
syndromic hearing loss in which the transmission of
sound signals from the inner ear to the auditory nerve
and brain is impaired. In the present study, we applied
whole-exome sequencing of two affected siblings with
ANSD and their healthy sisters from a Chinese family in
Guangxi Zhuang Autonomous Region. For the first time,
two compound heterozygous mutations, c.1273C > T
(R425X) and c.4994 T > C (L1665P), in the OTOF gene




A total of 127 patients who were diagnosed as NSHL
were enrolled at The People’s Hospital of Guangxi
Autonomous Region. Peripheral blood samples were
collected for genomic DNA. Audiologic tests were
performed as necessary. The audiologic tests include
auditory brainstem response (ABR), auditory steady-
state response (ASSR), distortion product otoacoustic
emission (DPOAE) and cochlear microphonic (CM)
tests.
Hereditary deafness gene mutation screening and
whole-exome sequencing
All the 127 cases enrolled in our study were subjected to
a preliminary screening using a microarray method with
a Hereditary Deafness Gene Mutation Detection Kit
(CapitalBio Technology Co., Ltd. Beijing, China). The kit
was designed to detect fifteen well-documented muta-
tions in four deafness-associated genes, including GJB2:
35delG, 176_191del16, 235delC, 299_300delAT; GJB3:
538C > T; 12S rRNA: 1555A > G, 1494 T > C; and
SLC26A4: IVS7-2A > G, 2168A > G, 1174A > T, 1226G >
A, 1229C > T, 1975G > C, 2027 T > A, and IVS15 + 5G >
A. Furthermore, The subsequent whole-exome sequen-
cing was applied to the cases with singularity of its
phenotype as following standard protocol by Capital-
Bio Technology Co., Ltd. Genomic DNA was ex-
tracted using a RelaxGene Blood DNA System
(TIAGEN Biotech Co., Ltd. Beijing, China). Libraries
were prepared using the Ion AmpliSeq™ Exome RDY
Kit (Thermo Fisher Scientific Inc. Shanghai, China).
We used the Ion OneTouch™ 2 System (Thermo
Fisher) to prepare enriched, template-positive Ion PI™
Ion Sphere™ particles (ISPs) containing clonally ampli-
fied DNA. The template was sequenced on the Ion
Proton™ System (Thermo Fisher) with the Ion PI™
Chip Kit v3 (Thermo Fisher). The average sequencing
depth of 86.1× provided sufficient depth to identify
variants for 90.9% of the targeted exome.
Variant analysis
The coverage analysis plugin and variant caller plugin
from Life Technologies (Thermo Fisher) were used to
analyze the Ion Proton sequencing run. Variant discov-
ery, genotype calling of multi-allelic substitutions and
indels were performed on each individual sample using
the Torrent Variant Caller (TVC, version 4.6.0.7)
(Thermo Fisher). Statistics and graphs describing the
level of sequence coverage produced for targeted gen-
omic regions were provided by the Torrent Coverage
Analysis (version 4.6.0.3). The variants were annotated
by the Annotate variants 5.0 of Ion Reporter (Thermo
Fisher).
Direct Sanger sequencing
The potential causative variants in the family were con-
firmed by Sanger sequencing of amplified PCR products.
Primer sequences for the pathogenic variant in the OTOF
gene (NM_194248.2) were designed using Primer Premier
5.0 as follow: c.1273-F 5′- GGGAATCAATGAATCCTGT
CT-3′ and c.1273-R 5′- TCCACGAGGTCCTTGTTTT-
3′, c.4994-F 5′- GGTAGACAGGTGATGGCATAG-3′
and c.4994-R 5′- TGTCAAGGACCCAGTTCATC-3′.
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Results
Clinical data and audiological assessments
Through the preliminary hereditary deafness gene muta-
tion screening, previously well-characterized mutations
were found in only 8.7% (11/127) of the patients with
non-syndromic hearing loss (NSHL) enrolled in our
study, which was described in our earlier work [7].
In a family with NSHL collected in this study, the par-
ents had normal hearing, while their two sons had ab-
normal hearing, and their daughter had normal hearing
(Fig. 1a). Both hearing impaired subjects II:1 and II:3
presented with abnormal pronunciation and poor re-
sponses to sound. The general physical examinations of
the two siblings were normal. Magnetic resonance im-
aging (MRI) showed that the structures of the inner ear
in subjects II:1 and II:3 were normal (Additional file 1:
Figure S1). The audiological assessments revealed that
both two siblings had bilateral sensorineural deafness.
The results of audiological assessments of the two af-
fected subjects are summarized in Table 1 and the re-
sults for II:3 are shown in Fig. 2a, b, c, and d.
The affected subject II:1 underwent a right-side coch-
lear implant at the age of 18, and his pronunciation and
response to the sound had improved since then. In
addition, the affected subject II:3 had worn hearing aids
in both ears since the hearing screening at the time of
birth, but his ability to communicate was not improved.
At 20 months of age, he underwent right-side cochlear
implantation at The People’s Hospital of Guangxi
Zhuang Autonomous Region. The surgery was success-
ful, and no postoperative complications were observed.
Then, he underwent speech rehabilitation training for
more than 1 year. His speech was excellent, and he had
a good response to sounds and therefore he has been en-
rolled in regular kindergarten. According to the audio-
logical assessments and the history of the treatments
and the outcomes, the two siblings were clinical diag-
nosed as ANSD.
Whole-exome sequencing and variant analysis
Of all the patients evaluated in our study with non-
syndromic hearing loss (NSHL), well-known mutations
in four deafness-associated genes (GJB2, GJB3, 12S
rRNA, and SLC26A4) were only detected in 8.7% (11/
127) of the patients [7], suggesting that unappreciated
genetic abnormalities may contribute to hearing loss dis-
eases. We then introduced whole-exome sequencing to
identify the novel mutations in the subjects of interest.
A summary of the whole-exome sequencing data for the
three samples of the family are shown in Table 2. There
were 95,317,441 total reads, and there was an average
read length of 179 bp. The total number of bases was
17.1 G, and 98% of the sequenced bases mapped to the
human reference genome [8].
The variant calling pipeline of Life Technologies was
used to analyze the Ion Proton sequencing run. Ion Pro-
ton identified (37,918; 37,729; and 38,169) SNPs among
three samples of the family (Table 2). The SNPs were an-
notated by the Annotate variants 5.0 of Ion Reporter
(Life Technologies). Known variants with minor allele
frequency (MAF) >1% were removed. The variants were
filtered according to the inheritance model (autosomal
Fig. 1 Pedigree and sequence analysis of OTOF mutations in the ANSD family. a In a Chinese ANSD family, compound heterozygous mutations
c.1273 C > T and c.4994 T > C were observed in both affected siblings (II:1 and II:3); b One heterozygous mutation c.1273 C > T was observed in
the sister (II:2). The c.1273 C > T heterozygous mutation is from the father (I:1), and the other heterozygous c.4994 T > C mutation is from the
mother (I:2)
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recessive with both homozygous and compound hetero-
zygous) and variant function categories, including mis-
sense, nonsense and frameshift mutations. The
pathogenicity predictor softwares SIFT and Polyphen
were used to predict the novel missense variant.
We then focused our attention to the variants that
were associated with reported deafness genes. Two com-
pound heterozygous mutations of the OTOF gene
(R425X and L1665P) were identified in the deaf patients
in the family (Fig. 1b). The novel missense variant
reported in our study has not been found in dbSNP
database (https://www.ncbi.nlm.nih.gov/projects/SNP/),
1000-Genomes Project (http://phase3browser.1000gen-
omes.org/index.html) and NHLBI Exome Sequencing
Project (http://evs.gs.washington.edu/EVS).
Identification of pathogenic mutations
The c.1273C > T (p.R425X) mutation in the OTOF gene
contributes to a premature stop codon may result in a
truncated polypeptide that strongly suggests its contri-
bution to the pathogenicity for ANSD (Fig. 3a). The
amino acid L1665 is conserved across mammalian spe-
cies, including humans, rats, dogs, mice and chimpan-
zees (Fig. 3b); c.4994 T > C (p.L1665P) was predicted to
be harmful.
Two mutations of the OTOF gene (p.R425X and
p.L1665P) were verified in the ANSD family by Sanger
Sequencing. The results validated that both compound
heterozygous mutations of the OTOF gene can be de-
tected in the two affected siblings; however, their parents
and sister were heterozygous carriers of c.1273C > T
(father and sister) and c.4994 T > C (mother), showing a
Fig. 2 Audiologic tests of subject II:3. Subject II:3 was diagnosed with ANSD according to the audiological assessments; a ABR, auditory brainstem
responses; b ASSR, auditory steady-state response; c DPOAE, distortion product otoacoustic emissions; and d CM, cochlear microphonics
Table 1 Audiological assessments of the affected subjects
Subjects Age Sex ASSR DPOAE ABR CM
II:1 18 M Bil profound Present Absent Present
II:3 3 M Bil profound Present Absent Present
ASSR auditory steady-state response, ABR auditory brainstem responses,
Bil bilateral, DPOAE distortion product otoacoustic emissions, CM cochlear
microphonics, F female; and M, male
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complete match of the genotype with the phenotype
(Fig. 1a).
Discussion
Although the majority of NSHL cases have confirmed
Mendelian inheritance caused by single gene mutations,
many deaf individuals do not have identified genetic
contributions. WES provides a highly efficient strategy
to identify the genetic variation that is responsible for
Mendelian diseases. This study identified two disease-
causing mutations in the OTOF gene in a Chinese family
with ANSD by WES. The mutations in this gene were
observed in the Chinese deaf population for the first
time.
Auditory neuropathy is viewed as a variety of hearing
loss in which the outer hair cells within the cochlea are
usually functional, but the sound signals are unable to
be accurately transmitted to the auditory nerve and
brain also known as auditory neuropathy/auditory dys-
synchrony (AN/AD) or auditory neuropathy spectrum
disorder (ANSD). Audiology characteristics of ANSD
contain severely abnormal or absent ABRs that begin
with the VIII nerve component of wave I and preserve
normal or near-normal otoacoustic emissions. ANSD
can occur independently or be accompanied by other
neurological symptoms, such as Charcot-Marie-Tooth
disease [9]. The causes of ANSD are complex, which
mainly include specific damage to the inner hair cells,
synaptopathies and VIII nerve disorders. Genetic factors
nearly account for 40% of all ANSD cases [10]. Four loci
have been identified to account for non-syndromic
ANSD; the mutations in the OTOF and PJVK genes
cause autosomal recessive ANSD, the mutations in the
AUNA1 causes autosomal dominant ANSD, and the mu-
tations in the AUNX1 causes X-linked ANSD [10–15].
OTOF was first identified using a candidate gene ap-
proach and a positional cloning strategy in 1999. This
48-exon gene, encoding otoferlin, is located on Chromo-
some 2p23.1 [11]. OTOF encodes four transcript iso-
forms as different translation start sites combined with
alternative splicing of some exons. Long isoforms with
six C2 domains can be detected in humans and mice,
whereas the short isoforms with three C2 domains are
only detected in humans [16, 17]. Otoferlin is highly
expressed in the inner ear hair cells (IHCs) and vesti-
bule. Otoferlin functions for hearing has been well-
characterized. To trigger exocytosis of neurotransmitter
in a calcium-dependent manner, Otoferlin interacts with
two members of presynaptic SNARE complex (Syntaxin1
and SNAP25) at ribbon synapses of cochlear IHCs,
which are incorporated into the membranes of transport
vesicles during budding and associated with nerve ter-
minal membranes [18, 19]. These findings revealed that
Fig 3 Schematic structure of otoferlin and conservation analysis. a The functional domains of otoferlin and location of the mutations identified in
the study. b Conservation of the L1665P of otoferlin. TMD: the transmembrane domain
Table 2 Whole-exome sequencing of the three siblings
Parameter II:1 II:2 II:3
Total reads 29,611,231 29,893,511 33,929,246
Number of mapped reads 29,123,517 29,600,865 33,598,112
Percent reads on target 88.85% 89.52% 91.11%
Uniformity of base coverage 94.32% 95.08% 94.18%
Mean Read Length 176 bp 181 bp 181 bp
Mean read depth 79.68 82.84 95.77
Target base coverage at 20× 91.96% 93.78% 93.78%
Total number of variants 37918 37729 38169
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Otoferlin is essential for the synaptic vesicle exocytosis
and may acts as a sensor that triggers membrane fusion
at the IHC ribbon synapse.
Mutations in the OTOF gene have been reported as
the main cause of non-syndromic recessive ANSD. To
date, more than 100 pathogenic mutations related to sub-
jects with NSHL, including ANSD, have been found in dif-
ferent populations [20]. The c.2485 C > T (p.Q829X)
mutation was frequently found in Spanish populations
and has also been observed in French, Mexicans, Argenti-
nians and English populations [21–24]. Varga et. al.
observed 4 OTOF mutations in three non-syndromic re-
cessive auditory neuropathy (NSRAN) families; two non-
sense mutations, c.6141G >A and c.6285C >G; and two
splice site mutations, IVS39 + 1G >C and 1778delG [25].
There were eleven probable pathogenic variants were
found among 160 unrelated ANSD patients in Japan [26].
In China, more than 40 mutations of the OTOF gene have
been identified. Zhang’s team found 15 novel mutations in
14 congenital ANSD patients [27].
In this study, for the first time, two mutations in the
OTOF gene were observed in a Chinese family with
ANSD by whole-exome sequencing. The otoferlin iso-
form a is encoded by OTOF and consists of 1997 amino
acids (aa), including six C2 domains, C2A (2–97 aa),
C2B (255–353 aa), C2C (418–529 aa), C2D (961–1068
aa), C2E (1493–1592 aa), and C2F (1733–1863 aa)
(Fig. 3a). The c.1273C > T mutation, results in a prema-
ture stop codon from arginine to a terminator
(p.R425X). It may lead to abnormal or nonfunctional
protein products, suggesting it is responsible for the
pathogenicity of deafness. Previously, this mutation was
reported in a deaf population in Pakistan [28], and this
is the first time the mutation was identified in the Chin-
ese population. The novel missense mutation c.4994 T >
C, located between the C2E and C2F domains, results in
a single amino acid substitution, leucine to proline
(p.L1665P). Three pathogenic mutations (E1661K,
R1676C, and E1700Q) between C2E and C2F domains
have been reported. The missense mutation c.4994 T > C
(p.L1665P) was assumed to be pathogenic because 1)
mutations in OTOF have been reported to be the main
cause of autosomal recessive non-syndromic deafness
DFNB9 that associated with ANSD [11, 17]; 2) the re-
gion is highly conserved across mammalian species
(Fig. 3b); 3) it was found in compound heterozygosity
with p.R452X; 4) some pathogenic mutations have been
found near the mutation site; and 5) no other recessive
variants related to deafness could be identified by WES.
In this study, we found two mutations of the OTOF
gene in a Chinese family with ANSD located in the
Guangxi Zhuang Autonomous Region. The findings in-
dicate that there may be rare mutations or genes associ-
ated with NSHL in the Zhuang Autonomous Region,
which is one of the ethnic minority regions in China.
The mutation frequency and hot spots of the deafness
gene may differ among disparate ethnic regions and peo-
ples. The findings provide new evidence for investiga-
tions of the mutation characteristics of the OTOF gene
in NSHL in the Zhuang population in China.
Conclusion
We identified two disease-causing mutations in the
OTOF gene in a Chinese family with ANSD by WES.
Two compound heterozygous mutations of the OTOF
gene were detected in two affected siblings. Out data in-
dicated that WES is an effective approach for identifying
the genetic characteristics of non-syndromic ANSD. The
identification of these two mutations extends the muta-
tion spectrum of the OTOF gene in the Chinese deaf
population. The findings will hopefully facilitate genetic
diagnosis and enable otolaryngologists to select appro-
priate clinical interventions for patients with ANSD.
Additional file
Additional file 1: Figure S1. Magnetic resonance imaging (MRI) of
the inner ear in subject II:3. A single layer scanning of inner ear
(left panel) and multilayer 3D reconstruction image (right panel) are
shown. (TIF 285 kb)
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